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subpopulations in patients with severe trauma
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【Abstract】Objective:    To investigate the effect
and clinical significance of Xuebijing injection on periph-
eral T-lymphocyte subpopulations in patients with severe
trauma.
Methods:    Thirty-three patients with severe trauma
were randomly divided into a control group (n=16) and a
treatment group (n=17). The patients of two groups were all
treated conventionally, and the only difference was that
Xuebijing injection was given to patients of the treatment
group. The CD4
+ and CD8
+ subpopulations of T-lympho-
cyte in the peripheral blood were detected respectively on
admission, 3rd and 5th days after trauma by double anti-
body labeling and flow cytometry.
Results:    The CD4
+ T-lymphocytes and CD4
+/CD8
+ ra-
tio of peripheral blood in patients with severe trauma de-
creased markedly on the 3rd and 5th days after trauma.
Furthermore, compared with control group, the peripheral
CD4
+ T-lymphocytes and CD4
+/CD8
+ ratio of treatment group
renewed obviously on the 5th day after trauma, and showed
statistical differences (P<0.05).
Conclusion:    In the treatment of patients with severe
trauma, the early use of Xuebijing injection is effective in
correcting disorder or suppression of T-lymphocyte sub-
populations regulating network, and promoting a more bal-
anced profile of immunologic function.
Key words:    Wounds and injuries; T-lymphocyte,
helper-inducer; Flow cytometry; Medicine, Chinese tra-
ditional
With the development of the society, the in-cidence of trauma is progressively in-creased and trauma turns to be more se-
vere and complex. According to statistics, trauma is
the main cause for disability (people under the age of
65 years) and death (people under the age of 45 years).
Serious injury perturbs the immune system result-
ing in progressive dysfunction of immune responses
during the first week after trauma. These disorganized
immune responses are thought to contribute significantly
to the development of sepsis and multiorgan dysfunc-
tion syndrome (MODS), which are the leading causes
of death in patients who survive the initial injury.1-5 Regu-
lated inflammatory responses are generally considered
as a beneficial host response to injury, while posttrau-
matic hyperinflammation and ensuing immune incom-
petence are considered to be maladaptive and often
auto-destructive.1,6
In the recent traumatic immunomodulatory study,
the traditional Chinese medicine becomes highly em-
phasized for its therapeutic concepts of integrated and
balanced regulation. Xuebijing is an intravenous injec-
tion consisting of 5 traditional Chinese medicines (Flos
Carthami, Radix Paeoniae Rubra, Radix Salviae
Miltorrhiae, Radix Angelicae Sinensis, Ligusticum
Chuanxiong Hort) selected out from 36 traditional Chi-
nese herb compound formulas. A series of animal ex-
periments have revealed that Xuebijing injection has
some favorable immunomodulatory effects.7-11
Although the immune response to trauma is com-
plex and involves all inflammatory cells, T-lymphocytes
perform an important regulatory function and may play
a major role in the dysfunctional regulation of immune
function after trauma. Thus, the current clinical study
was undertaken to investigate the effect of Xuebijing
injection on regulating the immuno-inflammatory net-
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work after trauma by dynamically determining the
changes of peripheral T-lymphocyte subpopulations in
patients with severe trauma.
METHODS
Study population
This study was approved by the Ethics Committee
of Medical College, Zhejiang University, China. Thirty-
three patients with severe trauma hospitalized between
January 2006 and September 2007 were selected and
the criteria were as follows: (1) According to the opera-
tion records and final diagnosis of patients, the extent
of injuries was assessed using the Injury Severity Score
(ISS), an anatomical scoring system that provides an
overall score for the traumatic patients, and the
patients’s ISS scores were greater than or equal to 20.
(2) The patients were actively treated and did not die
within 72 hours after trauma. (3) The patients were in
good health condition previously and had no history of
heart, lung, brain, liver, kidney, metabolic or immune
diseases. (4) All subjects included in the study gave
their informed consent.
Of the series, there were 23 male patients and 10
female patients, aged 19-59 years (mean=38.6 years).
Nineteen patients were injured by traffic accidents, 8
by falling from a height, 3 by sharp instruments, 2 by
blunt ones, and 1 by crush.
Grouping and therapeutic scheme
Patients in this series were randomly divided into a
control group and a treatment group. In the control group,
16 patients (12 males and 4 females, aged 20-56 years)
were treated after admission according to the traumatic
conditions, such as by performing emergency
operations, preventing infection, providing nutritional and
multiple organ support, maintaining electrolytes and
acid-base equilibrium, and controlling hyperglycemia.
In the treatment group, 17 patients (11 males and 6
females, aged 19-59 years) received intravenous infu-
sion of 50 ml Xuebijing (Tianjin Chase Sun Pharmaceu-
tical CO. LTD, China; Batch number: 060818) plus 250
ml normal saline on the day of injury, twice a day for 5
days. Other treatment regimens were the same as the
control group.
As depicted in Table 1, the gender distribution, age
and ISS score of the patients in two groups were com-
pared by Student’s t test and Fisher exact probability
test, and the differences showed no statistical signifi-
cance (P>0.05).
Collection of blood samples
By using EDTAK2 anticoagulation, peripheral venous
blood samples (2 ml per sample) were taken from all
the patients on admission, the 3rd and 5th days, re-
spectively for determining the CD4
+ and CD8
+ subpopu-
lations of T-lymphocytes.
Flow cytometry analysis
T-lymphocyte surface receptors were determined by
double antibody labelling and flow cytometry. T-lym-
phocyte subpopulations analyzed included CD4/helper
and CD8/suppressor.
Fresh anti-coagulating blood (100 µl) was taken and
incubated at room temperature in the dark with an equal
volume of fluorescence-labelled monoclonal antibodies
(FITC-IgGl/PE-IgGl, FITC-CD4/PE-CD8, Caltag, USA).
A total of 500 µl optilyse C was added, and the mixture
was re-incubated at room temperature for 8 minutes.
Two ml PBS was added after complete lysis of the red
blood cells. After washing and centrifugation (1100 r/min),
the samples were thoroughly mixed with 1 ml PBS and
then analyzed by flow cytometer (FACSCalibur, B-D, USA).
Statistical analysis
Quantitative data were presented as mean±standard
deviation (SD). Fisher exact probability test, homoge-
neity test, t test, two-way analysis of variance and least
significant difference-t (LSD-t) analysis were used for
statistical analysis on SPSS 13.0 software package.
Differences were considered significant when P<0.05.
RESULTS
Treatment and prognosis
Clinical outcomes of the patients including complica-
tions and prognosis were recorded routinely (Table 2).
Systemic inflammation response syndrome (SIRS), sep-
sis (SIRS with infection), and organ dysfunction were
documented using established criteria.12-13
Of all 16 cases in the control group, 11 received
emergency operations, 3 died of late multiple organ fail-
ure or sepsis, and 1 died of cerebral hernia. For the
treatment group, emergency operations were performed
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in 10 patients and 3 died of multiple organ failure and
sepsis in the later period. The incidence rates of sep-
sis and MODS in the control group were slightly higher
than those in the treatment group. However, no signifi-
cant differences were found in the complications and
prognosis of the two groups (P>0.05).
Variation of T-lymphocyte subpopulations in pe-
ripheral blood
The T-lymphocyte subpopulations in peripheral blood
of patients in two groups were detected, and the re-
sults were presented in Tables 3-5. On admission, the
peripheral CD4
+, CD8
+ T-lymphocyte and CD4
+/CD8
+ ra-
tio in the two groups showed no significant differences,
whereas the peripheral CD4
+ T-lymphocyte and CD4
+/CD8
+
ratios in the two groups were all remarkably decreased
on the 3rd day and 5th day after trauma (P<0.01).
Meanwhile, the peripheral CD8
+ T-lymphocyte showed
no obvious change during the experimental period.
Table 5. Peripheral CD4
+/CD8
+ ratio changes of two groups (χ ± s)
Groups                      n              On admission          3rd day                 5th day              F values        P values
Control group            16              1.60±0.20            1.11±0.20*          1.15±0.20*           44.598            0.000
Treatment group       17              1.66±0.24            1.20±0.22*          1.32±0.24*           17.959            0.000
t values                                           0.704                  1.221                    2.267
P values                                          0.487                   0.231                    0.031
                    *P<0.01, as compared with on admission.
Table 4. Peripheral CD8
+ T-lymphocytes changes of two groups (χ ± s)
Groups                    n               On admission           3rd day               5th day              F values         P values
Control group          16                28.67±6.16          29.49±4.68         30.09±3.69             0.646             0.531
Treatment group      17               28.47±5.88           29.11±4.33         29.45±3.42             0.264             0.770
t values                   0.092                   0.247                  0.512
P values                   0.928                   0.806                  0.613
Table 1. Comparison of gender, age, and ISS of patients between two groups (χ ± s )
Groups                         n            Gender (male∶female)             Age (year)                              ISS
Control group              16                     12∶4                             32.88±10.99                     31.25±10.85
Treatment group          17                     11∶6                             34.88±11.45                     29.88±8.62
P values                                                0.708                                   0.612                                 0.690
Table 2. Comparison of complications and prognosis between two groups
                                            Survival                       Sepsis (n,%)                                MODS (n, %)
                                             (n, %)                 Yes                       No                  Yes                          NoGroups                   n
Control group        16        12 (75.0%)     12 (75.0%)            4 (25.0%)          9 (56.3%)              7 (43.7%)
Treatment group    17        14 (82.6%)     10 (58.8%)            7 (41.2%)         8 (47.1%)              9 (52.9%)
P values                                 0.688                              0.465                                             0.732
Table 3. Peripheral CD4
+ T-lymphocytes changes of two groups (χ ± s)
Groups                    n             On admission            3rd day            5th day                  F values         P values
Control group      16               45.09±6.57          32.40±6.02*       34.19±5.63*           39.149            0.000
Treatment group    17               46.10±6.02          34.30±5.46*       38.55±6.47*▲        34.917            0.000
t values                 0.460                     0.951                  2.061
P values                 0.649                     0.349                  0.048
*P<0.01, as compared with on admission; ▲ P<0.01 as compared with the 3rd day after trauma.
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On the 5th day after trauma, the peripheral CD4
+ T-
lymphocyte and CD4
+/CD8
+ ratio in the treatment group
renewed notably, showing statistically significant dif-
ference compared with the control group (P<0.05).
Furthermore, compared with the 3rd day after trauma,
the peripheral CD4
+ T-lymphocyte in the treatment group
was markedly increased on the 5th day, and the differ-
ence was considered significant (P<0.01).
DISCUSSION
The immuno-inflammatory response is dependent
on intercellular communication through modification of
cytokine response and fluctuation of peripheral immune
cells such as natural killer (NK) cells, B cells, and T-
lymphocyte subpopulations (CD4
+ and CD8
+ cells). It is
well-known that T-lymphocytes express either the CD4
or the CD8 receptor on their surface. The CD4
+ T-lym-
phocyte subpopulation is also called Help T cell (TH
cell), and can be generally divided into three subpopu-
lations of TH0, TH1, and TH2. TH0 cells are the original
CD4
+ T-lymphocytes, and can differentiate into the ma-
ture TH1 or TH2 cells by signal-activating in the
microenvironment. TH1 cells mainly participate in pro-
moting cell-mediated immune response, augmenting
IgM and IgG2 synthesis by B cells, and activating
macrophages. TH2 cells are concerned with promoting
antibody-mediated immune response, leading to IgG1
and IgE responses, and increased numbers of local
and/or circulating eosinophils. The CD8
+ T-lymphocyte
subpopulation can be divided into two subpopulations
of suppressor T cell (TS cell) and cytotoxic T cell (TC
cell). TS cells can quickly terminate or suppress
immuno-inflammatory responses and TC cells can ef-
fectively kill the target through one or at least two dis-
tinct mechanisms. The CD4
+ and CD8
+ subpopulations
collaborate and restrict each other, playing important
modulation roles in the immuno-inflammatory reactions
of the body to infection and injury. Consequently, the
ratio of CD4
+/CD8
+ cells is fairly constant among
individuals, which can effectively reflect balanced con-
dition between pro-inflammatory and anti-inflammatory
processes.14
Previous studies have showed that the immune func-
tion often disordered or maladjusted after the body suf-
fered severe trauma, and it can be reflected on the signs
of excessive inflammatory response in the early stage
of trauma and subsequent suppression of adaptive
immunity.13,15 This suppression, especially occurred in
the T-lymphocyte mediated immune response, would
obviously weaken the body immune function and in-
cline the body to infection and organ failure, mainly pre-
sented as the peripheral CD4
+ and CD8
+ T-lymphocyte
viability impairment, CD4
+/CD8
+ ratio decrease, NK cell
and lymphokine activated killer cell (LAK cell) viability
reduction and so on. This sequence of events is thought
to have very important clinical consequences since
sepsis and MODS are the most frequent causes of death
in patients who survive the first 24 hours.3,15 The results
of this study also indicate the instant immuno-inflam-
matory regulation function disorder or inhibition in these
patients, in view of the fact that peripheral CD4
+ T-lym-
phocyte and CD4
+/CD8
+ ratio markedly declined on the
3rd and 5th days after trauma. Consequently, balanced
inflammatory responses are generally considered as a
beneficial host response to injury.16
Xuebijing is an intravenous injection consisting of 5
traditional Chinese medicines selected out from 36 tra-
ditional Chinese herb compound formulas. It is based
on the “bacteria, endotoxin, inflammatory mediator
treated simultaneously” theory proposed by Professor
Wang Jinda.10 A series of animal experiments have fully
demonstrated that Xuebijing injection can antagonise
the disruptive effects of endotoxin, regulate body im-
mune functions, decrease the stress-induced organ or
tissue damage (liver, lung, endothelium of blood vessels,
etc.), and notably improve the survive rate of animals
with SIRS or MODS.7-11 Moreover, according to some clini-
cal researches, early Xuebijing injection treatment showed
favorable therapeutic effects and reliable safety on the
patients with severe trauma, sepsis or MODS.17-20
Our data from the present study showed that on the
5th day after trauma, the peripheral CD4
+ subpopula-
tion of T-lymphocyte and CD4
+/CD8
+ ratio in the treat-
ment group renewed notably, showing statistically sig-
nificant difference compared with the control group. It
indicates that for patients with severe trauma, an early
use of Xuebijing injection can contribute to restoring
the CD4
+/CD8
+ ratio of peripheral blood, regulating the
immune function, shortening the duration of disorder or
suppression of T-lymphocyte subpopulations regulat-
ing network, and thereby promoting a more balanced
profile of immunologic function.
In summary, we found that the immuno-inflamma-
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tory regulating function would be disordered or sup-
pressed after the body suffered severe trauma, and an
early use of Xuebijing injection was effective in correct-
ing disorder or suppression of T-lymphocyte subpopu-
lations regulating network and promoting a balanced
profile of immunologic function, which may be one of
the protective mechanisms of Xuebijing injection. This
study also provided a new viewpoint for the develop-
ment of traditional Chinese herb to treat patients with
severe injury. However, as for the molecular mecha-
nism and concrete signal transduction process in
Xuebijing regulating network, they still need further study.
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